Below are the most recent publications written about "Acute Coronary Syndrome" by people in Profiles.
-
Mir T, Uddin M, Changal K, Qureshi W, Weinberger J, Wani J, Maganti K, Rab T, Eltahawy E, Sheikh M. Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study. Int J Cardiol. 2022 06 01; 356:6-11.
-
Hariri E, Kassas I, Hammoud MA, Hansra B, Akhter MW, Fisher DZ, Smith CS, Barringhaus KG. Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes. Am Heart J. 2022 04; 246:125-135.
-
Locuratolo N, Scicchitano P, Antoncecchi E, Basso P, Bonfantino VM, Brescia F, Carrata F, De Martino G, Landriscina R, Lanzone S, Lillo A, Massari F, Musci S, Palumbo V, Paolillo C, Rutigliano D, Rutigliano S, Sublimi Saponetti L, Scalera G, Spadafina T, Squiccimarro E, Tota F, Caldarola P. [Follow-up of patients after an acute coronary event: the Apulia PONTE-SCA program]. G Ital Cardiol (Rome). 2022 Jan; 23(1):63-74.
-
Chen J, Kiefe CI, Gagnier M, Lessard D, McManus D, Wang B, Houston TK. Non-specific pain and 30-day readmission in acute coronary syndromes: findings from the TRACE-CORE prospective cohort. BMC Cardiovasc Disord. 2021 08 09; 21(1):383.
-
Ding EY, Mehawej J, Abu H, Lessard D, Saczynski JS, McManus DD, Kiefe CI, Goldberg RJ. Cardiovascular Health Metrics in Patients Hospitalized with an Acute Coronary Syndrome. Am J Med. 2021 11; 134(11):1396-1402.e1.
-
Ocon AJ, Reed G, Pappas DA, Curtis JR, Kremer JM. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ann Rheum Dis. 2021 12; 80(12):1522-1529.
-
Soares WE, Knee A, Gemme SR, Hambrecht R, Dybas S, Poronsky KE, Mader SC, Mader TJ. A Prospective Evaluation of Clinical HEART Score Agreement, Accuracy, and Adherence in Emergency Department Chest Pain Patients. Ann Emerg Med. 2021 08; 78(2):231-241.
-
Soueid AE, Kassas I, Rade J, Kakouros N. Evaluation of a Real-World In-Hospital Antiplatelet-Switching Strategy Following Coronary Interventions: The SWITCH Study. J Invasive Cardiol. 2021 04; 33(4):E263-E268.
-
Fletcher EK, Wang Y, Flynn LK, Turner SE, Rade JJ, Kimmelstiel CD, Gurbel PA, Bliden KP, Covic L, Kuliopulos A. Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2021 05 05; 41(5):e265-e279.
-
Qureshi WT, Kakouros N, Fahed J, Rade JJ. Comparison of Prevalence, Presentation, and Prognosis of Acute Coronary Syndromes in =35 years, 36 - 54 years, and = 55 years Patients. Am J Cardiol. 2021 02 01; 140:1-6.